Insiders · Profile

THIEL PETER

Director at Palantir Technologies · 10% owner at Chemomab Therapeutics · Director at AbCellera Biologics · and 1 more. Filing since 22 May 2012. CIK 0001211060

Company
Date
Role
Action
Shares
Amount
Of holding
2 Mar 2026
Director
Sold on a plan
2,000,000
$289.71M
12.7%
1 Oct 2024
Director
Sold on a plan
4,242,000
$155.66M
11.0%
30 Sep 2024
Director
Sold on a plan
4,181,118
$154.32M
9.8%
27 Sep 2024
Director
Sold on a plan
3,989,204
$147.37M
8.5%
26 Sep 2024
Director
Sold on a plan
4,561,502
$169.09M
8.9%
25 Sep 2024
Director
Sold on a plan
4,254,666
$156.44M
7.7%
24 Sep 2024
Director
Sold on a plan
7,362,247
$271.46M
11.7%
10 May 2024
Director
Sold on a plan
5,000,000
$103.92M
24.1%
9 May 2024
Director
Sold on a plan
1,669,411
$35.49M
2.6%
8 May 2024
Director
Sold on a plan
6,285,833
$134.08M
8.9%
12 Mar 2024
Director
Sold on a plan
7,044,756
$174.62M
9.0%
13 Aug 2021
Director
Sold, plan not stated
3,262
$81.55K
100%
16 Mar 2021
10% owner
Bought
230,536
no price
26.3%
18 Feb 2021
Director
Sold, plan not stated
20,003,915
$504.78M
100%
15 Dec 2020
Director
Bought
3,000,000
$60.00M
41.8%
2 Oct 2020
Director
Sold, plan not stated
908
$8.30K
97.4%
1 Oct 2020
Director
Sold, plan not stated
2,386,104
$23.28M
97.8%
1 Oct 2020
Director
Sold, plan not stated
1,983,906
$19.35M
48.7%
30 Sep 2020
Director
Sold, plan not stated
23,013,764
$235.83M
100%
6 Feb 2020
Director
Sold, plan not stated
53,602
$11.29M
100%
22 Aug 2019
Director
Sold, plan not stated
22,246
$4.05M
100%
27 Jul 2018
Director
Sold, plan not stated
2,256
$396.95K
100%
20 Nov 2017
Director
Sold, plan not stated
160,805
$28.77M
75.0%
28 Jul 2017
Director
Sold, plan not stated
60,316
$10.39M
100%
22 Nov 2016
Director
Sold, plan not stated
20,104
$2.45M
100%
2 May 2016
Director
Sold, plan not stated
857,626
$101.06M
80.0%
11 Aug 2015
Director
Sold, plan not stated
1,072,033
$100.41M
50.0%
27 Aug 2014
Director
Sold, plan not stated
293,096
$21.93M
100%
27 Aug 2014
Director
Sold, plan not stated
37,242
$2.79M
100%
27 Aug 2014
Director
Sold, plan not stated
29,654
$2.22M
100%
27 Aug 2014
Director
Sold, plan not stated
20,568
$1.54M
100%
29 Jul 2014
Director
Sold, plan not stated
374,677
$27.77M
100%
29 Jul 2014
Director
Sold, plan not stated
120,273
$8.92M
100%
17 Aug 2012
Director
Sold, plan not stated
5,784,174
$111.50M
73.0%
17 Aug 2012
Director
Sold, plan not stated
1,032,114
$19.90M
67.6%
17 Aug 2012
Director
Sold, plan not stated
130,365
$2.51M
26.0%
17 Aug 2012
Director
Sold, plan not stated
101,028
$1.95M
3.8%
17 Aug 2012
Director
Sold, plan not stated
6,446
$124.26K
26.0%
17 Aug 2012
Director
Sold, plan not stated
3,941
$75.97K
26.0%
16 Aug 2012
Director
Sold, plan not stated
10,653,661
$212.87M
57.3%
16 Aug 2012
Director
Sold, plan not stated
1,901,014
$37.98M
55.5%
16 Aug 2012
Director
Sold, plan not stated
240,115
$4.80M
32.4%
16 Aug 2012
Director
Sold, plan not stated
186,077
$3.72M
3.7%
16 Aug 2012
Director
Sold, plan not stated
11,874
$237.25K
32.4%
16 Aug 2012
Director
Sold, plan not stated
7,259
$145.04K
32.4%
22 May 2012
Director
Sold, plan not stated
14,293,769
$537.16M
43.5%
22 May 2012
Director
Sold, plan not stated
2,550,546
$95.85M
100%
47 decisions on file.